Safety of Sublingual dmLT for ETEC
Condition: Gastroenteritis Escherichia Coli
Interventions: Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine; Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified December 7, 2016
Interventions: Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine; Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified December 7, 2016